Clinical potential of low molecular weight heparins

Semin Thromb Hemost. 1989 Oct;15(4):405-8. doi: 10.1055/s-2007-1002739.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Review

MeSH terms

  • Cardiopulmonary Bypass
  • Clinical Trials as Topic
  • Fibrinolytic Agents / adverse effects
  • Fibrinolytic Agents / therapeutic use*
  • Hemorrhage / chemically induced
  • Heparin / adverse effects
  • Heparin / immunology
  • Heparin / therapeutic use
  • Heparin, Low-Molecular-Weight / adverse effects
  • Heparin, Low-Molecular-Weight / antagonists & inhibitors
  • Heparin, Low-Molecular-Weight / therapeutic use*
  • Humans
  • Postoperative Complications / prevention & control
  • Protamines / pharmacology
  • Pulmonary Embolism / drug therapy
  • Renal Dialysis
  • Thrombocytopenia / etiology
  • Thrombophlebitis / drug therapy
  • Thrombophlebitis / prevention & control

Substances

  • Fibrinolytic Agents
  • Heparin, Low-Molecular-Weight
  • Protamines
  • Heparin